Hot Pursuit     08-Jun-24
Gland Pharma appoints Srinivas Sadu as executive chairman & CEO
The pharmaceutical company on Friday announced that it has appointed Srinivas Sadu as executive chairman and chief executive officer (CEO) of the company, with effect from 10 June 2024.

In a regulatory filing, the company said, “Srinivas Sadu, the incumbent managing director (MD) and CEO, has been appointed as executive chairman and CEO of the company, effective 10 June 2024.”

Srinivas Sadu, a seasoned professional with over two decades of experience, has been a key part of Gland’s journey. He assumed the role of MD and CEO on 25 April 2019, and has been instrumental in the company's growth and success. His career with the company began in 2000, and he steadily rose through the ranks to become chief operating officer in 2011, said the firm.

Gland Pharma is one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India, and other markets. It has a wide range of injectables, including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions, oncology, and ophthalmic solutions. The company also pioneered Heparin technology in India.

The pharma company reported a consolidated net profit of Rs 192.42 crore in Q4 FY24, steeply higher than Rs 78.68 crore posted in Q4 FY23. Revenue from operations soared 95.85% to Rs 1,537.5 crore during the quarter as against Rs 785.01 crore recorded in Q4 FY23.

The scrip gained 1.05% to end at Rs 1,856 on the Friday, 7 June 2024.

Previous News
  Gland Pharma appoints Srinivas Sadu as executive chairman & CEO
 ( Hot Pursuit - 08-Jun-24   13:23 )
  Gland Pharma receives USFDA approval for Eribulin Mesylate Injection
 ( Corporate News - 06-Apr-24   17:40 )
  Gland Pharma consolidated net profit declines 19.55% in the September 2023 quarter
 ( Results - Announcements 06-Nov-23   17:42 )
  Gland Pharma Ltd slips for fifth straight session
 ( Hot Pursuit - 20-Feb-23   09:32 )
  Gland Pharma Ltd stays supported
 ( Hot Pursuit - 04-Apr-22   13:05 )
  Gland Pharma Ltd soars 0.86%, gains for fifth straight session
 ( Hot Pursuit - 09-Jun-23   13:00 )
  Gland Pharma appoints Srinivas Sadu as Executive Chairman and CEO
 ( Corporate News - 08-Jun-24   12:56 )
  Gland Pharma allots 6,200 equity shares under ESOS
 ( Corporate News - 14-Feb-24   15:10 )
  Gland Pharma IPO subscribed 4%
 ( IPO Centre - IPO News 09-Nov-20   17:31 )
  Gland Pharma IPO subscribed 2.06 times
 ( IPO Centre - IPO News 12-Nov-20   09:30 )
  Gland Pharma receives US FDA nod for immunostimulant Plerixafor
 ( Hot Pursuit - 07-May-24   12:21 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top